SYNJ1 Gene PARK20 Parkinson NGS Genetic DNA Test
Comprehensive Genetic Testing for Parkinson’s Disease
The SYNJ1 Gene PARK20 Parkinson NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with PARK20 Parkinson’s disease. This advanced testing methodology provides crucial insights for individuals and families affected by early-onset Parkinsonism, enabling proactive healthcare management and personalized treatment approaches.
What Does This Test Measure?
This sophisticated genetic analysis specifically targets the SYNJ1 gene, which encodes synaptojanin-1, a protein essential for synaptic vesicle recycling in nerve cells. The test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the entire SYNJ1 gene sequence, identifying:
- Point mutations and single nucleotide variants
- Insertions and deletions affecting gene function
- Copy number variations impacting gene dosage
- Pathogenic variants linked to autosomal recessive Parkinsonism
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Early-onset Parkinsonism symptoms before age 40
- Progressive neurological deterioration with Parkinsonian features
- Family history of Parkinson’s disease or movement disorders
- Unexplained tremors, rigidity, or bradykinesia
- Developmental delay followed by Parkinsonian symptoms
- Consanguineous family background with neurological conditions
Clinical Benefits of SYNJ1 Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Early Diagnosis: Enables timely intervention before significant neurological damage occurs
- Personalized Treatment: Guides targeted therapeutic approaches based on genetic profile
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Prognostic Insights: Helps predict disease progression and potential complications
- Differential Diagnosis: Distinguishes PARK20 from other Parkinsonian syndromes
Understanding Your Test Results
Our comprehensive genetic report provides detailed interpretation of your SYNJ1 gene analysis:
- Positive Result: Indicates presence of pathogenic SYNJ1 mutations, confirming PARK20 diagnosis
- Negative Result: Suggests alternative causes for Parkinsonian symptoms, requiring further investigation
- Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation
- Carrier Status: Determines if individuals carry single copies of mutated genes
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art genetic testing facilities ensure consistent, high-quality results regardless of your location.
Take Control of Your Neurological Health
Don’t let uncertainty about your neurological symptoms affect your quality of life. The SYNJ1 Gene PARK20 Parkinson NGS Genetic DNA Test provides the clarity needed for informed healthcare decisions. Our team of genetic counselors and neurologists are available to discuss your results and develop personalized management strategies.
Ready to schedule your genetic testing? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic predisposition to Parkinson’s disease and accessing targeted treatment options.
